Highly specific and ultrasensitive plasma test detects Abeta(1–42) and Abeta(1–40) in Alzheimer's disease

Ultrasensitive detection of beta-amyloid 1–42 as a relevant

IJMS, Free Full-Text

Comparison of ELISA- and SIMOA-based quantification of plasma Aβ ratios for early detection of cerebral amyloidosis, Alzheimer's Research & Therapy

PDF) The global Alzheimer's Association round robin study on plasma amyloid β methods

PDF) Highly Specific and Ultrasensitive Plasma Test Detects Abeta

Sensors, Free Full-Text

Amyloid beta (Aβ)1‐40 (top), Aβ1‐42 (middle), and Aβ1‐42/Aβ1‐40

Correlations of amyloid-β concentrations between CSF and plasma in

A blood-based biomarker workflow for optimal tau-PET referral in memory clinic settings

Aβ(1-38) reduces the β-sheet content and aggregation potential of

Full article: Novel bioengineered MBenes for the treatment of Alzheimer's disease: An in-Sillico study

Highly specific and ultrasensitive plasma test detects Abeta(1-42

Biomarkers for Alzheimer's disease-preparing for a new era of

Plasma A 42/40 plotted against CSF A 42/40 according to diagnostic

Combination of plasma amyloid beta(1-42/1-40) and glial fibrillary